| Zacks Company Profile for Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTSKY : OTC) |
|
|
| |
| • Company Description |
| Otsuka Holdings Co Ltd is a pharmaceutical company. It manufactures, sells, imports and exports pharmaceutical products, clinical testing and medical equipment for intractable diseases. Otsuka Holdings Co Ltd is based in Tokyo, Japan.
Number of Employees: 37,758 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $34.02 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 37,635 shares |
| Shares Outstanding: 1,074.19 (millions) |
| Market Capitalization: $36,543.78 (millions) |
| Beta: |
| 52 Week High: $37.52 |
| 52 Week Low: $23.31 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
1.22% |
0.48% |
| 12 Week |
-7.78% |
-10.30% |
| Year To Date |
20.08% |
7.80% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
2-16-4 Konan Minato-ku
-
TOKYO,M0 108-8241
JPN |
ph: 813-6717-1410
fax: - |
None |
http://www.otsuka.com/en |
|
|
| |
| • General Corporate Information |
Officers
Yoshiro Matsuo - Chief Executive Officer and President
Ichiro Otsuka - Chairman
Yuko Makino - Chief Financial Officer
Yoshiro Matsuo - Director
Shuichi Takagi - Director
|
|
Peer Information
Otsuka Holdings Co., Ltd. - Unsponsored ADR (GSAC)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (CASIF)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (ALCD.)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (OMNN)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (CGPI.)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 689164101
SIC: 8880
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 07/30/26
|
|
Share - Related Items
Shares Outstanding: 1,074.19
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $36,543.78 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.77% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.26 |
| Current Fiscal Year EPS Consensus Estimate: $1.96 |
Payout Ratio: 0.11 |
| Number of Estimates in the Fiscal Year Consensus: 2.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: 2.31% |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/30/26 |
|
|
|
| |
